Evolution Equity Partners announced the final closing of Evolution Technology Fund III, LP on April 16th, 2024, and total capital commitments of $ 1.1 Billion to back visionary entrepreneurs building next generation cybersecurity companies that safeguard the digital world. The fund raise was oversubscribed by existing and new limited partners representing a diversified mix of leading institutions, sovereign investors, insurance companies, endowments, foundations, fund of funds, family offices, and high-net-worth individuals. The capital commitment includes funding from British Patient Capital, the UK’s largest domestic investor in venture and venture growth opportunities and a subsidiary of the British Business Bank.
The capital committed gives Evolution Equity Partners a dedicated pool of capital to pursue opportunities for investment ranging from $20 million to $150 million in cybersecurity. The firm’s strategy is to build a well-diversified portfolio across key cybersecurity company building ecosystems in the United States, United Kingdom, the EU and Israel. Significant investments made to date by Evolution in the United Kingdom and EU include: AVG Technologies, Quantexa, Panaseer, DF Labs, Logpoint, CounterCraft, Cognitive Security, Eperi, Cybsafe, Tatum, Elliptic, Arqit, Metomic amongst 60 portfolio companies the firm has backed.
Richard Seewald, Founder and Managing Partner at Evolution Equity Partners, said, ” Over the past 25 years, we have witnessed firsthand the strong cybersecurity entrepreneurial talent pool in the UK and EU. First, while building AVG Technologies, a European based cybersecurity company that our team took public on the New York Stock Exchange in 2012 and thereafter in numerous European companies we have helped scale. For UK and EU based cybersecurity companies looking to build and grow internationally, Evolution is the ideal partner to equip companies with the knowledge, tools and strategy to drive performance and outcome. The expertise that Evolution has on the ground in Europe is unparalleled in the industry. We look forward to working with best of breed entrepreneurs and building European champions.”
Christine Hockley, Managing Director, Funds at British Patient Capital, said: “Evolution Equity Partners’ cybersecurity specialism coupled with proven investment credentials positions them to successfully support the UK’s leading technology companies as they scale. We are delighted to invest in this fund, which aligns with our objective of supporting promising companies to access the long-term financing they need to fulfil their growth potential.”
Evolution Equity Partners was founded by investor and technology entrepreneurs Richard Seewald and Dennis Smith, who manage and lead the firm, and a specialist team of 30 professionals based out of New York City, Palo Alto, London and Zurich. The team members have been founders, operating executives and investors in leading software companies around the world and are committed to the mission of helping exceptional entrepreneurs develop market leading companies. Evolution Equity Partners’ Centers of Excellence for Cybersecurity Growth, the firm’s high performance engine, has a clear goal: To provide the ultimate operating playbook on how to effectively take cybersecurity startups from idea to IPO and help equip companies with the knowledge, tools and strategy to drive performance.
Also Read:
Anrok secures USD 30Mln series B funding
TurbineOne raises USD 15Mln in series-A funding round
Foundational secures USD 8Mln in seed funding
